Disease | portal hypertension |
Comorbidity | |cirrhosis |
Sentences | 135 |
PubMedID- 24719556 | Background: oxidative stress is involved in the hypocontractility of visceral artery to vasoconstrictors and formation of hyperdynamic circulation in cirrhosis with portal hypertension. |
PubMedID- 23251280 | The patients all suffered from hepatic cirrhosis decompensation with portal hypertension. |
PubMedID- 25417057 | Lsm of cirrhosis patients with portal hypertension was significantly higher compared to those without portal hypertension (p < 0.05). |
PubMedID- 25037870 | Hcc patients seemed to suffer from less severe or shorter duration of portal hypertension compared with child-pugh class-matched cirrhosis patients. |
PubMedID- 25135728 | cirrhosis with portal hypertension is a common disease which has a significant impact on the quality of patients' life. |
PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
PubMedID- 24274743 | After feeding for 12 to 24 weeks, these animals may develop cirrhosis with portal hypertension. |
PubMedID- 25848469 | This review describes the recent developments in the pathobiology of endothelial dysfunction (ed) in the context of cirrhosis with portal hypertension and defines novel strategies and potential targets for therapy. |
PubMedID- 22333168 | Conclusion: the arb is effective in reducing portal hypertension in patients with cirrhosis, which is similar to propranolol. |
PubMedID- 25657603 | Progressive cirrhosis, with portal hypertension, is characterized by the development of portosystemic shunts and inadequately cleared circulating vasoactive substances eg, nitric oxide, vasoactive intestinal peptide, endocannabinoids, and bile salts, which create a state of splanchnic and arterial vasodilation, leading to ineffective central blood volume, initially compensated by high cardiac output.3,8 with worsening cirrhosis, systemic vascular resistance continues to fall, but cardiac compensation reaches a maximum. |
PubMedID- 24505457 | If untreated, ba progresses to cirrhosis, with portal hypertension and liver failure leading to death within two to three years. |
PubMedID- 26516439 | The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17). |
PubMedID- 20425483 | Presentations range from incidentally discovered cirrhosis to complications of advanced portal hypertension and hepatocellular cancer. |
PubMedID- 24502094 | Results: sixteen patients were found to have liver cirrhosis, three of them with portal hypertension. |
PubMedID- 21501480 | The obstruction of bile flow results in worsening cholestasis, liver fibrosis, and cirrhosis, which lead to portal hypertension and a decline in hepatic synthetic function. |
PubMedID- 24775062 | Pathology such as myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or antithrombin iii as well as hepatocellular carcinoma also could contribute to pvt. |
PubMedID- 21699820 | Tips has been used to manage the complications of portal hypertension in cirrhosis, including variceal hemorrhage and refractory ascites. |
PubMedID- 25053449 | Liver collagen in cirrhosis correlates with portal hypertension and liver dysfunction. |
PubMedID- 24563796 | Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension. |
PubMedID- 19918014 | We defined liver disease as one of the following: 1) abnormal liver function tests, 2) cirrhosis with portal hypertension, or 3) use of supplementary bile acids. |
PubMedID- 20968204 | The kidney in cirrhosis with portal hypertension. |
PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
PubMedID- 20300546 | To prevent immediate and late sequelae of hepatolithiasis, such as suppurative cholangitis, septicemia, secondary biliary cirrhosis with resultant portal hypertension, bleeding varices, and hepatic failure [5], aggressive treatment is needed. |
PubMedID- 20814511 | Surgical intervention in cirrhosis of liver with portal hypertension is associated with increased morbidity and mortality. |
PubMedID- 24729881 | 17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > uln to 1.5 × uln or ast/alt > uln to 2.5 × uln) and 1 patient additional liver cirrhosis with portal hypertension (score 3). |
PubMedID- 25543221 | Liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
PubMedID- 20616408 | cirrhosis leads to portal hypertension which induces portosystemic collaterals, allowing gut-derived humoral substances to directly enter the systemic circulation without detoxification by the liver. |
PubMedID- 24493093 | From 2,879 cases that underwent ce, 45 cirrhosis patients with portal hypertension (ph) were enrolled and divided into phe (n = 18) and non-phe (n = 27) groups. |
PubMedID- 24940392 | In addition, cirrhosis leads to portal hypertension and hyperdynamic circulation that can have widespread effects in the body (15). |
PubMedID- 23275766 | Upper gastrointestinal hemorrhage is a common complication of hepatic cirrhosis with systemic portal hypertension, while rarely caused by pancreatic diseases. |
PubMedID- 24748895 | Meanwhile, a clinical trial demonstrated that prophylactic use of ppis did not improve the portal hypertension-related bleeding in patients with cirrhosis (41). |
PubMedID- 21785606 | Intestinal bacterial overgrowth, seen in patients with advanced cirrhosis as a result of portal hypertension, has been noted to be a prerequisite for the facilitation of bacterial translocation. |
PubMedID- 22441510 | Conclusion: hscrp is elevated in patients with cirrhosis and is associated with portal hypertension and decreased survival. |